# CPTAC BIOSPECIMEN COLLECTION

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $7,357,801

## Abstract

The overall objective of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) is to improve our understanding of cancer biology by conducting proteogenomic analysis on selected cancer types where unanswered questions remain about the molecular biology of the disease. This analysis will add a complementary layer of protein molecular biology that facilitates refinement of driver genes, enhances understanding of the pathogenesis through proteomic subtyping, and illuminates dynamic alterations in posttranslational modifications (PTMs) responsible for the dysregulation of cancer signaling networks and pathways.

## Key facts

- **NIH application ID:** 10668926
- **Project number:** 75N91019D00024-P00003-759102000030-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** MATHANGI THIAGARAJAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $7,357,801
- **Award type:** —
- **Project period:** 2020-08-31 → 2025-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10668926

## Citation

> US National Institutes of Health, RePORTER application 10668926, CPTAC BIOSPECIMEN COLLECTION (75N91019D00024-P00003-759102000030-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10668926. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*